ProgressImage ProgressImage
Alembic Pharmaceuticals Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code 533573 border-img ISIN Demat INE901L01018 border-img Book Value 285.67 border-img NSE Symbol APLLTD border-img Div & Yield % 1.48 border-img Market Cap ( Cr.) 15913.75 border-img P/E 22.83 border-img EPS 35.46 border-img Face Value 2
ParticularsMar 2026
()
Mar 2025
()
Mar 2024
()
Mar 2023
()
Mar 2022
()
Mar 2021
()
INCOME :       
Sales Turnover 6651.386032.635874.065149.005035.415066.89
Excise Duty 0.000.000.000.000.000.00
Net Sales 6651.386032.635874.065149.005035.415066.89
Other Income 55.9060.75504.883.5551.1483.90
Stock Adjustments 121.15268.5452.36-72.84-19.85160.65
Total Income 6828.436361.926431.305079.715066.705311.44
EXPENDITURE :       
Raw Materials 2141.952057.311852.711587.291482.361464.67
Power & Fuel Cost 177.44179.67173.32151.19120.50118.31
Employee Cost 1612.901466.571335.911094.821062.30976.13
Other Manufacturing Expenses 434.18388.12327.87357.21324.10344.44
Selling & Administrative Expenses 1299.561269.901191.891173.001088.67848.55
Miscellaneous Expenses 110.7838.21519.7648.3228.8226.07
Less : Pre-operative Expenses Capitalised 0.000.000.000.000.000.00
Total Expenditure 5776.815399.785401.464411.834106.753778.17
Operating Profit 1051.62962.141029.84667.88959.951533.27
Interest 86.5176.4754.4749.0017.0212.98
Gross Profit 965.11885.67975.37618.88942.931520.29
Depreciation 311.00277.08271.14272.95284.92182.55
Profit Before Tax 654.11608.59704.23345.93658.011337.74
Tax 115.14105.4737.75-0.80114.46241.20
Fringe Benefit tax 0.000.000.000.000.000.00
Deferred Tax -101.450.000.000.000.000.00
Reported Net Profit 640.42503.12666.48346.73543.551096.54
Extraordinary Items -56.6620.180.990.052.815.20
Adjusted Net Profit 697.08482.94665.49346.68540.741091.34
Adjustment below Net Profit 0.000.003494.430.00-76.31-114.90
P & L Balance brought forward 4447.814160.910.002632.892440.831709.19
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 212.54216.220.00-672.06275.19250.00
P & L Balance carried down 4875.694447.814160.913651.682632.882440.83
Dividend 0.000.000.000.000.000.00
Preference Dividend 0.000.000.000.000.000.00
Equity Dividend % 600.00550.00550.00400.00500.00700.00
Dividend Per Share(Rs) 12.0011.0011.008.0010.0014.00
Earnings Per Share-Unit Curr 32.5825.6033.9117.6427.6555.79
Earnings Per Share(Adj)-Unit Curr 32.5825.6033.9117.6427.6555.79
Book Value-Unit Curr 285.69264.30249.75224.59269.16259.57
Book Value(Adj)-Unit Curr 285.69264.30249.75224.59269.16259.57
`

ATTENTION INVESTORS : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day ...Issued in the interest of investors.   Prevent Unauthorized Transactions in your demat account Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day...... issued in the interest of investors.    KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.      No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment.No worries for refund as the money remains in investor's account.

Investor Protection and Arbitration Exchange Circulars and Rules - NSE BSE

Filing of complaints on SCORES – Easy & quick   |    Advisory for Investors   |    AP Details - NSE   |    AP Details - BSE   |    AP Details - MCX
KYC Process Flow   |    Investor Grievance Redressal Process Flow   |   Online Grievance Redressal   |    Voluntary Freezing/Blocking of Trading Account   |    Website Accessibility Statement

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing.

x
x
×
Let's Chat
imsl-img
close
refresh